1. Home
  2. RCEL vs STRW Comparison

RCEL vs STRW Comparison

Compare RCEL & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • STRW
  • Stock Information
  • Founded
  • RCEL N/A
  • STRW 2015
  • Country
  • RCEL United States
  • STRW United States
  • Employees
  • RCEL N/A
  • STRW N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • STRW Real Estate Investment Trusts
  • Sector
  • RCEL Health Care
  • STRW Real Estate
  • Exchange
  • RCEL Nasdaq
  • STRW Nasdaq
  • Market Cap
  • RCEL 161.5M
  • STRW 133.6M
  • IPO Year
  • RCEL N/A
  • STRW N/A
  • Fundamental
  • Price
  • RCEL $5.19
  • STRW $10.99
  • Analyst Decision
  • RCEL Strong Buy
  • STRW Strong Buy
  • Analyst Count
  • RCEL 4
  • STRW 4
  • Target Price
  • RCEL $16.50
  • STRW $13.83
  • AVG Volume (30 Days)
  • RCEL 287.8K
  • STRW 41.3K
  • Earning Date
  • RCEL 08-07-2025
  • STRW 08-11-2025
  • Dividend Yield
  • RCEL N/A
  • STRW 5.12%
  • EPS Growth
  • RCEL N/A
  • STRW 34.22
  • EPS
  • RCEL N/A
  • STRW 0.58
  • Revenue
  • RCEL $71,661,000.00
  • STRW $126,557,000.00
  • Revenue This Year
  • RCEL $57.29
  • STRW $15.21
  • Revenue Next Year
  • RCEL $28.07
  • STRW $2.21
  • P/E Ratio
  • RCEL N/A
  • STRW $19.14
  • Revenue Growth
  • RCEL 41.35
  • STRW 22.41
  • 52 Week Low
  • RCEL $5.10
  • STRW $8.70
  • 52 Week High
  • RCEL $14.16
  • STRW $12.90
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 29.07
  • STRW 58.72
  • Support Level
  • RCEL $5.10
  • STRW $10.43
  • Resistance Level
  • RCEL $6.33
  • STRW $11.25
  • Average True Range (ATR)
  • RCEL 0.32
  • STRW 0.51
  • MACD
  • RCEL 0.02
  • STRW 0.10
  • Stochastic Oscillator
  • RCEL 6.10
  • STRW 79.32

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About STRW Strawberry Fields REIT Inc.

Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.

Share on Social Networks: